Follow the ESSILORLUXOTTICA share price and the full insider trade history of the company, a listed equity based in France. Shares are quoted on FR FR, under the oversight of AMF. Operating in the Healthcare & Pharma sector, ESSILORLUXOTTICA has published 192 public disclosures. Market capitalisation: €79.1bn. The latest transaction was disclosed on 19 June 2026 (Cession). Among the most active insiders: DELFIN SARL SOCIETE A RESPONSABILITE LIMITEE. All data is free.
Analysts rate ESSILORLUXOTTICA Buy (bullish), based on 23 analysts. Average price target: €251.91.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
25 of 192 declarations
EssilorLuxottica is a global leader in vision care, eyewear and optical solutions, combining ophthalmic lenses, frames, sunglasses, connected eyewear, optical retail and med-tech solutions. The Group describes itself as fully integrated across the value chain, from R&D and manufacturing to omnichannel distribution through a broad network of stores and professional partners. In 2024, EssilorLuxottica generated revenue of €26.5 billion, confirming its scale and leadership position in the global eyewear industry. The company’s history reflects the combination of two iconic optical businesses: Essilor, carrying a long French industrial heritage in lenses, and Luxottica, the Italian powerhouse known for frames and branded eyewear. Their combination created EssilorLuxottica, now regarded as the benchmark global player in the sector. The Group’s stated mission is to help people “see more and be more,” linking vision health, personal style and broader access to high-quality eye care. EssilorLuxottica’s main business lines cover prescription and therapeutic lenses, vision protection and performance solutions, frames and sunglasses under some of the industry’s most recognizable brands, as well as fast-growing areas such as wearables and med-tech. Its portfolio includes leading technologies and brands such as Varilux, Stellest, Transitions, Ray-Ban, Oakley and Supreme, alongside retail banners including Sunglass Hut, LensCrafters, Vision Express and Apollo. The Group is also investing in digital health, AI-enabled solutions, smart glasses and eye-care related instruments. The company’s competitive strength comes from its vertical integration, brand power and global commercial footprint. At the end of 2024, EssilorLuxottica employed more than 200,000 people, operated in 150 countries and had around 18,000 stores, supported by a sizeable portfolio of patents, designs and trademarks. Its international presence spans North America, EMEA, Asia-Pacific and Latin America. Recent highlights include continued growth in 2024, strong free cash flow and the acceleration of new categories such as connected eyewear and med-tech solutions. Beyond its industrial and commercial reach, EssilorLuxottica relies on a sustained innovation agenda and a strong social commitment through the OneSight EssilorLuxottica Foundation, which works to expand sustainable access to vision care worldwide. This combination of global leadership, product innovation and distribution depth makes the company one of Europe’s most prominent listed names in the health and vision-care universe.